Vitamin D analogue (cholecalciferol)
Pregnancy: Considered safe and recommended at standard doses. NICE recommends 10 mcg (400 IU) daily for all pregnant and breastfeeding women.
Colecalciferol (Vitamin D3)
Brand names: Fultium-D3, Desunin, Invita D3, Stexerol-D3, Aviticol, Pro D3
Adult dose
Dose: Maintenance / preventive: 800–2000 IU OD (NOS 2018 guidelines). Loading regimens for proven deficiency (25-OH vit D <25 nmol/L): 50,000 IU once weekly for 6 weeks (total 300,000 IU); or 20,000 IU twice weekly for 7 weeks; or 4000 IU OD for 10 weeks. Then maintenance 800–2000 IU OD.
Route: Oral
Frequency: Once daily (maintenance) or once weekly (loading)
Max: 10,000 IU/day chronic; loading regimens up to 50,000 IU/week
Take with main fatty meal for absorption. Many UK products are fungal-derived — confirm vegetarian/vegan acceptability with patient.
Paediatric dose
Route: Oral
Frequency: Once daily
Universal supplementation (NICE PH56): birth–4 yrs 400 IU OD; >4 yrs and adults at risk 400–800 IU OD. Treatment of rickets/deficiency: <6 months 3000 IU OD for 8–12 weeks; 6 mo–12 yrs 6000 IU OD for 8–12 weeks; >12 yrs adult dose. BNFc.
Dose adjustments
Renal
Use alfacalcidol or calcitriol if eGFR <30 — colecalciferol requires renal 1α-hydroxylation.
Hepatic
Caution; severe hepatic impairment may impair 25-hydroxylation.
Clinical pearls
- Universal recommendation in UK (NICE PH56, RCPCH, NHS): 400 IU/day for ALL infants and toddlers, and 400 IU/day for adults at risk (limited sun exposure, dark skin, elderly, pregnant, breastfeeding) — OTC pharmacy supply.
- Diagnosis: 25-hydroxyvitamin D level (NOT 1,25). Deficiency <25 nmol/L; insufficiency 25–50; sufficient ≥50. Recheck 3 months after loading — measuring earlier is unreliable.
- ALWAYS check calcium and renal function before high-dose loading — granulomatous disease (sarcoidosis, TB, lymphoma) can cause life-threatening hypercalcaemia with vitamin D supplementation.
- Vegan/halal: most UK preparations are sheep-wool lanolin derived; D3 from lichen is available (e.g., Vitabiotics) for vegans.
- Combination with calcium (Adcal-D3, Accrete D3) for osteoporosis prevention/management — note increased CV risk signal with HIGH calcium intake (>1500 mg/day).
- After bariatric surgery: high-dose colecalciferol commonly required (3000–6000 IU/day); annual monitoring.
Contraindications
- Hypercalcaemia or vitamin D toxicity
- Metastatic calcification
- Renal calculi (active)
- Sarcoidosis or other granulomatous disease (relative — extra-renal 1α-hydroxylation can cause hypercalcaemia)
- Williams syndrome
Side effects
- Hypercalcaemia (rare at typical doses; risk with very high cumulative doses or granulomatous disease)
- Hypercalciuria, nephrocalcinosis (with chronic high dose)
- Constipation, GI upset
- Headache
- Pruritus, rash (rare)
Interactions
- Thiazide diuretics: additive ↑ Ca — caution combining at high doses
- CYP3A4 inducers (phenytoin, carbamazepine, phenobarbital, rifampicin): ↑ vitamin D metabolism — consider higher dose
- Orlistat: ↓ absorption — separate by ≥2 hours
- Cholestyramine, colestipol: ↓ absorption
- Glucocorticoids (long-term): antagonise vitamin D effects on calcium absorption
- Digoxin: hypercalcaemia ↑ digoxin toxicity
Monitoring
- 25-OH vitamin D 3 months after loading then annually if deficient
- Adjusted calcium at baseline; recheck if symptoms or high-dose loading
- Renal function in elderly/CKD
Reference: BNFc; BNF 90; BNF for Children 2024; NICE PH56 (Vitamin D 2014, updated 2017); NOS Vitamin D & Bone Health 2018; RCPCH Vitamin D Guidance. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016